How have HLN shares performed this year?

Haleon's stock was trading at $8.23 at the beginning of the year. Since then, HLN shares have increased by 12.1% and is now trading at $9.2250. View the best growth stocks for 2024 here .

How were Haleon's earnings last quarter?

Haleon plc (NYSE:HLN) announced its quarterly earnings data on Wednesday, May, 1st. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. The business had revenue of $3.70 billion for the quarter, compared to analysts' expectations of $3.71 billion. Haleon had a net margin of 9.68% and a trailing twelve-month return on equity of 13.17%.

Who are Haleon's major shareholders?

Top institutional shareholders of Haleon include Douglas Lane & Associates LLC (0.19%), Raymond James & Associates (0.09%), Bank of New York Mellon Corp (0.03%) and GAM Holding AG (0.02%).

How do I buy shares of Haleon?

Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Top-Rated Dividend StocksTop-Rated Dividend

NYSE:HLN

Haleon (HLN) Stock Price, News & Analysis

$9.22

+0.08 (+0.87%)

(As of 07/26/2024 ET)

Compare

Today's Range: $9.14
▼
$9.28
50-Day Range: $8.27
▼
$9.13
52-Week Range: $7.70
▼
$9.28

Volume: 6.84 million shs
Average Volume: 5.23 million shs
Market Capitalization: $42.12 billion

P/E Ratio: 30.75
Dividend Yield: 2.28%
Price Target: N/A

Get Haleon alerts:

Haleon MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Healthy
0.39% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.53
Based on 7 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 8.51%
From $0.47 to $0.51 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.47 out of 5 stars

Medical Sector

308th out of 936 stocks

Toilet Preparations Industry

6th out of 14 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Haleon.
Read more about Haleon's stock forecast and price target.

5.0

Short Interest

Percentage of Shares Shorted
0.39% of the float of Haleon has been sold short.
Short Interest Ratio / Days to Cover
Haleon has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Haleon has recently decreased by 7.72%, indicating that investor sentiment is improving significantly.

2.5

Dividend Strength

Dividend Yield
Haleon pays a meaningful dividend of 2.38%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Haleon does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Haleon is 70.00%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Haleon will have a dividend payout ratio of 41.18% next year. This indicates that Haleon will be able to sustain or increase its dividend.
Read more about Haleon's dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for HLN.

3.1

News and Social Media Coverage

News Sentiment
Haleon has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Haleon this week, compared to 2 articles on an average week.
Search Interest
10 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 900% compared to the previous 30 days.
MarketBeat Follows
4 people have added Haleon to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Haleon insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 6.67% of the stock of Haleon is held by institutions.
Read more about Haleon's insider trading history.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Haleon are expected to grow by 8.51% in the coming year, from $0.47 to $0.51 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Haleon is 30.75, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.35.
Price to Earnings Ratio vs. Sector
The P/E ratio of Haleon is 30.75, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 156.32.
Price to Earnings Growth Ratio
Haleon has a PEG Ratio of 2.58. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Haleon has a P/B Ratio of 2.05. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.
Read more about Haleon's valuation and earnings.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Heard about the 72-Hour Profit Surge? Read this…

One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…

Click here now to get all the details.

About Haleon Stock (NYSE:HLN)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

HLN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HLN Stock News Headlines

July 25 at 4:20 AM | americanbankingnews.com

Reviewing Haleon (NYSE:HLN) & Waldencast (NASDAQ:WALD)

July 19, 2024 | markets.businessinsider.com

Barclays Keeps Their Buy Rating on Haleon PLC (HLN)

July 26, 2024 | American Hartford Gold Group (Ad)

Prepare for a Recession Unlike Any Other

Dave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.

July 17, 2024 | americanbankingnews.com

Short Interest in Haleon plc (NYSE:HLN) Increases By 6.6%

June 26, 2024 | reuters.com

Haleon to sell nicotine replacement therapy business outside US for $633 mln

June 3, 2024 | prnewswire.com

Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition

May 17, 2024 | benzinga.com

GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale

May 17, 2024 | reuters.com

GSK raises $1.5 bln from offloading Haleon stake at a discount

July 26, 2024 | American Hartford Gold Group (Ad)

Dave Ramsey Makes Big Mistake Live On Air

May 16, 2024 | reuters.com

GSK intends to sell its remaining stake in Haleon

May 7, 2024 | seekingalpha.com

Haleon: Pressures Are Temporary, But Closer To Fair Value

May 2, 2024 | msn.com

Sensodyne-maker Haleon posts tepid sales as demand for some products cools off

May 2, 2024 | seekingalpha.com

Sales Call

May 1, 2024 | investing.com

Haleon shares slide as revenue declines

May 1, 2024 | reuters.com

Haleon's first-quarter revenue misses expectations

April 30, 2024 | msn.com

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30, 2024 | proactiveinvestors.com

Haleon eyes job cuts as UK manufacturing site 'no longer viable'

April 30, 2024 | reuters.com

Sensodyne-maker Haleon to shut UK manufacturing site, with more than 400 jobs hit

See More Headlines

Receive HLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/16 Dividend: 3/14/2024
Last Earnings: 5/01/2024
Dividend Payable: 5/16/2024
Today: 7/26/2024
Next Earnings (Confirmed): 8/01/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Toilet preparations
Sub-Industry: N/A
Current Symbol: NYSE:HLN
CUSIP: N/A
CIK: 1900304
Web: www.haleon.com
Phone: 44-19-3282-2000
Fax: N/A
Employees: 25,408
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.30
Trailing P/E Ratio: 30.87
Forward P/E Ratio: 19.70
P/E Growth: 2.58
Net Income: $1.30 billion
Net Margins: 9.68%
Pretax Margin: 14.40%
Return on Equity: 13.17%
Return on Assets: 6.43%

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 1.04
Quick Ratio: 0.73

Sales & Book Value

Annual Sales: $14.05 billion
Price / Sales: 3.01
Cash Flow: $0.38 per share
Price / Cash Flow: 24.52
Book Value: $4.51 per share
Price / Book: 2.05

Miscellaneous

Outstanding Shares: 4,566,150,000
Free Float: N/A
Market Cap: $42.28 billion
Optionable: Not Optionable
Beta: 0.24

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Brian James McNamara (Age 58)
CEO & Executive Director
Comp: $4.32M
Mr. Tobias Hannes Hestler (Age 52)
CFO & Executive Director
Comp: $2.4M
Ms. Sonya Ghobrial (Age 50)
Head of Investor Relations
Ms. Tamara Rogers (Age 54)
Chief Marketing Officer
Mr. Filippo Lanzi
President of EMEA & LatAm
Mr. Keith Choy (Age 55)
President of Asia Pacific
Ms. Lisa Paley (Age 57)
President of North America
Mr. Franck Riot (Age 56)
Chief R&D Officer
Mr. Bjorn Timelin
Head of Strategy
Ms. Namrata P. Patel (Age 58)
Chief Supply Chain Officer

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

Should I Buy Haleon Stock? HLN Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Haleon plc:

Haleon plc reported earnings per share (EPS) of $0.12 for the last quarter, exceeding analysts' estimates by $0.01. This indicates strong financial performance.
Analysts have given Haleon plc a consensus rating of "Moderate Buy," suggesting positive sentiment and growth potential in the stock.
Recent institutional investments in Haleon plc, such as Procyon Advisors LLC increasing its stake by 559.9%, indicate confidence in the company's future prospects.
Positive analyst coverage from reputable firms like HSBC and Berenberg Bank, both issuing "buy" ratings for the stock, further supports the investment case for Haleon plc.
Despite trading down slightly, Haleon plc's stock price remains stable around $8.43, presenting a potentially attractive entry point for investors.

Cons

Investors should be bearish about investing in Haleon plc for these reasons:

While the company's EPS performance was positive, the revenue of $3.70 billion for the last quarter was slightly below analyst estimates, indicating potential challenges in revenue growth.
There is a debt-to-equity ratio of 0.53 for Haleon plc, which may raise concerns about the company's leverage and financial stability.
Market trading data shows a slight decline in Haleon plc's stock price, which could be a red flag for short-term investors looking for immediate gains.
The company's quick ratio of 0.73 and current ratio of 1.04 may suggest liquidity challenges or difficulties in meeting short-term obligations.
While analysts have given positive ratings, the stock has only one "hold" rating, indicating some uncertainty or mixed opinions among analysts regarding the future performance of Haleon plc.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 2, 2024. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

HLN Stock Analysis - Frequently Asked Questions

How have HLN shares performed this year?: Haleon's stock was trading at $8.23 at the beginning of the year. Since then, HLN shares have increased by 12.1% and is now trading at $9.2250.
View the best growth stocks for 2024 here.
How were Haleon's earnings last quarter?: Haleon plc (NYSE:HLN) announced its quarterly earnings data on Wednesday, May, 1st. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. The business had revenue of $3.70 billion for the quarter, compared to analysts' expectations of $3.71 billion. Haleon had a net margin of 9.68% and a trailing twelve-month return on equity of 13.17%.
Who are Haleon's major shareholders?: Top institutional shareholders of Haleon include Douglas Lane & Associates LLC (0.19%), Raymond James & Associates (0.09%), Bank of New York Mellon Corp (0.03%) and GAM Holding AG (0.02%).
How do I buy shares of Haleon?: Shares of HLN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.